CAS RN: 458531-57-2
Carbamic acid, [(1S)-1-methyl-2-oxo-3-butenyl]-, 1,1-dimethylethyl ester (9CI)
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 458531-57-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Shanghai
Inquiry
458531-57-2 / tert-butyl N-[(2S)-3-oxopent-4-en-2-yl]carbamate
Standard CAS: 458531-57-2
Multi CAS: No
Basic Information
copy
CAS
458531-57-2 copy
Multi CAS
No copy
Molecular Formula
C10H17NO3 copy
Molecular Weight
199.250000 copy
Exact Mass
199.120843 copy
InChI
InChI=1S/C10H17NO3/c1-6-8(12)7(2)11-9(13)14-10(3,4)5/h6-7H,1H2,2-5H3,(H,11,13)/t7-/m0/s1 copy
InChIKey
TUQPRWAHCDKMKC-ZETCQYMHSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Fraction Csp3
0.6 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
54.04 copy
TPSA
55.4 copy
LogP / Solubility
WLOGP
1.65 copy
MLOGP
1.46 copy
XLogP3
1.7 copy
Consensus LogP
1.6 copy
Log S (ESOL)
-1.92 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.39 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.69 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.76 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy